Proveca is a UK-based pharmaceutical company specialising in the design & licensing of medicines for children for a variety of therapy areas. Learn more.
Location: United Kingdom, England, Manchester
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Albion Cap... | albion.cap... |
Mentions in press and media 3
| Date | Title | Description |
| 14.08.2025 | The Marketing Authorisation Application (MAA) for CT001 is submitted to the European Medicines Agency (EMA) for acute pain management in children | The Marketing Authorisation Application (MAA) for CT001 is submitted to the European Medicines Agency (EMA) for acute pain management in children Thu, Aug 14, 2025 18:00 CET Report this content Proveca has submitted a Paediatric Use Marketi... |
| 26.08.2024 | Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001 | Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001 Mon, Aug 26, 2024 08:30 CET Report this content Cessatech and Proveca enter an exclusive agreement for the commercialization of CT001 world-wide excludi... |
| - | Albion Capital on the hunt for £80 million in new venture capital trust fundraise | London’s Albion Capital has announced its intention to raise £80 million with provisions for an additional £20 million in aggregate across its six funds. In total, these funds account for approximately £545 million in AUM. Focusing primaril... |